Advertisement

Seven Neurons of Psychopharmacology: Adaptive Regulation in Biogenic Amine Neurons

Chapter
  • 42 Downloads

Abstract

The mind of the medical clinician, no less than that of the researcher, travels often to models of physiological function. Although he knows such cartoonlike, mechanistic scenarios to be less than perfect, they serve to organize his observations. Vague discomfort arises when one must make such models explicit, for we know there is evidence missing for many steps in their pictorial development and the false steps we must knowingly take to ensure their continuity. Likewise, I didn’t enjoy the news that the mathematical models used to predict the tides for the next ten years had nothing to do with the mechanisms of tide formation, or the fact that Wall Street chartists often don’t know anything about the companies the stock prices of which they predict. Chloral hydrate does not decompose to chloroform in the body, even though a century ago this explanatory model predicted much of its clinical pharmacology: latency, duration, interactions with other drugs, and effects of overdose. The bromides are not antiepileptic because they reduce the frequency of masturbation, although that was the reason given for their first use.

Keywords

Tyrosine Hydroxylase Biogenic Amine Psychotropic Drug Model Neuron Tryptophan Hydroxylase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abita, J., Milstien, S., Chang, N., and Kaufman, S., 1976, In vitro activation of rat liver phenylalanine hydroxylation by phosphorylation, J. Biol. Chem. 251:5310.PubMedGoogle Scholar
  2. Aghajanian, G. K., Haigler, H. J., and Bloom, F. E., 1972, Lysergic acid diethylamide and serotonin: Direct actions on serotonin containing neurons in rat brain, Life Sci. 11:615.CrossRefGoogle Scholar
  3. Alousi, A., and Weiner, N., 1966, The regulation of norepinephrine synthesis in sympathetic nerves: Effect of nerve stimulation, cocaine, and catecholamine-releasing agents, Proc. Natl. Acad. Sci. U.S.A. 56:1491.PubMedCrossRefGoogle Scholar
  4. Axelrod, J., 1959, Metabolism of epinephrine and other sympathomimetic amines, Physiol. Rev. 39:751.PubMedGoogle Scholar
  5. Buff, K., and Dairman, W., 1975, Biosynthesis of biopterin by two clones of mouse neuroblastoma, Mol. Pharmacol. 11:87.PubMedGoogle Scholar
  6. Bullard, W. P., Mandell, A. J., and Russo, P. V., 1976, Dyanamics and disposition of reduced pterins in the rat brain (abstract), Society for Neuroscience.Google Scholar
  7. Carlsson, A., Fuxe, K., Hamberger, B., and Lindqvist, M., 1966, Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons, Acta Physiol. Scand. 67:481.PubMedCrossRefGoogle Scholar
  8. Cohen, E. L., and Wurtman, R. L., 1976, Brain acetylcholine: Control by dietary choline, Science 191:561.PubMedCrossRefGoogle Scholar
  9. Costa, E., Guidotti, A., and Zivkovic, B., 1974, Short-and long-term regulation of tyrosine hydroxylase, in: Neuropsychopharmacology of Monoamines and Their Regulatory Enzymes (E. Usdin, ed.) pp. 161–175, Raven Press, New York.Google Scholar
  10. Dahlstrom, A., 1971, Axoplasmic transport (with particular respect to adrenergic neurons), Philos. Trans. R. Soc. London 261:325.CrossRefGoogle Scholar
  11. von Euler, U.S., 1958, The presence of the adrenergic neurotransmitter in intraaxonal structures, Acta Physiol. Scand. 43:155.CrossRefGoogle Scholar
  12. Fisher, D. B., and Kaufman, S., 1973, The stimulation of rat liver phenylalanine hydroxylase by lysolecithin and α-chymotrypsin, J. Biol. Chem. 248:4345.PubMedGoogle Scholar
  13. Gallager, D. W., and Aghajanian, G. K., 1975, Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3H-serotonin: Correlations with serotonergic impulse flow, J. Pharmacol. Exp. Ther. 193:785.PubMedGoogle Scholar
  14. Groves, P. M., Wilson, C. J., Young, S. J., and Rebec, G. V., 1975, Self-inhibition by dopaminergic neurons, Science 190:522.PubMedCrossRefGoogle Scholar
  15. Ikeda, M., Fahien, L. A., and Udenfriend, S., 1966, A kinetic study of bovine adrenal tyrosine hydroxylase, J. Biol. Chem. 241:4452.PubMedGoogle Scholar
  16. Joh, T. H., Geghman, C., and Reis, D. J., 1973, Immunochemical demonstration of increased tyrosine hydroxylase protein in sympathetic ganglia and adrenal medulla elicited by reserpine, Proc. Natl. Acad. Sci. U.S.A. 70:2767.PubMedCrossRefGoogle Scholar
  17. Kaufman, S., 1967, Pteridine cofactors, Annu. Rev. Biochem. 36:171.PubMedCrossRefGoogle Scholar
  18. Kirshner, N., 1962, Uptake of catecholamines by a particulate fraction of the adrenal medulla, J. Biol. Chem. 237:2311.PubMedGoogle Scholar
  19. Knapp, S., and Mandell, A. J., 1975, Effect of lithium chloride on parameters of biosynthetic capacity for 5-hydroxytryptamine in rat brain, J. Pharmacol. Exp. Ther. 193:812.PubMedGoogle Scholar
  20. Knapp. S., Mandell, A. J., and Bullard, W. P., 1975, Calcium activation of brain tryptophan hydroxylase, Life Sci. 16:1583.PubMedCrossRefGoogle Scholar
  21. Kopin, I. J., 1964, Storage and metabolism of catecholamines: The role of monamine oxidase, Pharmacol. Rev. 16:179.PubMedGoogle Scholar
  22. Kuczenski, R. T., and Mandell, A. J., 1972, Regulatory properties of soluble and particulate rat brain tyrosine hydroxylase, J. Biol. Chem. 247:3114.PubMedGoogle Scholar
  23. Lloyd, T., and Kaufman, S., 1974, The stimulation of partially purified bovine caudate tyrosine hydroxylase by phosphatidyl-L-serine, Biochem. Biophys. Res. Commun. 59:1262.PubMedCrossRefGoogle Scholar
  24. Mandell, A. J. (ed.), 1975, Neurobiological mechanisms of presynaptic metabolic adaptation and their organization: Implications for a pathophysiology of the affective disorders, in: Neurobiological Mechanisms of Adaptation and Behavior, pp. 1–32, Raven Press, New York.Google Scholar
  25. Mandell, A. J., and Knapp, S., 1976, A neurobiological model for the symmetrical prophylactic action of lithium in bipolar affective disorder, Pharmakopsychiatr. Neuro-Psychopharmakol. (Stuttgart) 9:116.Google Scholar
  26. Moir, A. T. B., and Eccleston, D., 1968, The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles, J. Neurochem. 15:1093.PubMedCrossRefGoogle Scholar
  27. Mueller, R. A., Thoenen, H., and Axelrod, J., 1969, Inhibition of transsynaptically increased tyrosine hydroxylase activity by cycloheximide and actinomycin D, Mol. Pharmacol. 5:463.PubMedGoogle Scholar
  28. Musacchio, J., D’Angelo, G. L., and McQueen, C. A., 1971, Dihydropteridine reductase: Implication on the regulation of catecholamine biosynthesis, Proc. Natl. Acad. Sci. U.S.A. 68:2087.PubMedCrossRefGoogle Scholar
  29. Neff, N. H., and Costa, E., 1968, Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration, J. Pharmacol. Exp. Ther. 160:40.PubMedGoogle Scholar
  30. Oldendorf, W. H., 1971, Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection, Am. J. Physiol. 221:1629.PubMedGoogle Scholar
  31. Paoletti, R., Sirtori, C., and Spano, P. F., 1975, Clinical relevance of drugs affecting tryptophan transport, Annu. Rev. Pharmacol. 15:73.PubMedCrossRefGoogle Scholar
  32. Raese, J., Patrick, R. L., and Barchas, J. D., 1976, Phospholipid-induced activation of tyrosine hydroxylase from rat brain striatal synaptosomes, Biochem. Pharmacol. 25:2245.PubMedCrossRefGoogle Scholar
  33. Segal, D. S., Sullivan, J. L., Kuczenski, R. T., and Mandell, A. J., 1971, Effects of long term reserpine treatment on brain tyrosine hydroxylase and behavioral activity, Science 173:847.PubMedCrossRefGoogle Scholar
  34. Segal, M., and Bloom, F. E., 1974, The action of norepinephrine in the rat hippocampus Brain Res. 72:79.PubMedCrossRefGoogle Scholar
  35. Trendelenburg, U., 1959, The supersensitivity caused by cocaine, J. Pharmacol. Exp. Ther. 125:55.PubMedGoogle Scholar
  36. Udenfriend, S., 1966, Tyrosine hydroxylase, Pharmacol. Rev. 18:43.PubMedGoogle Scholar
  37. Weiner, N., and Rabadjija, M., 1968, The regulation of norepinephrine synthesis. Effect of puromycin on the accelerated synthesis of norepinephrine associated with nerve stimulation, J. Pharmacol. Exp. Ther. 164:103.PubMedGoogle Scholar
  38. Wurtman, R. J., and Fernstrom, J. D., 1974, Effects of diet on brain neurotransmitters, Nutr. Rev. 32:193.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  1. 1.School of MedicineUniversity of California at San DiegoLa JollaUSA

Personalised recommendations